论文部分内容阅读
目的研究适合国内小核酸制药产业的发展模式。方法通过分析小核酸产业状况、国内外小核酸发展模式和企业专利技术特点,确定适合国内产业的发展模式。结果在对现有状况进行评价的基础上,确定了适合国内小核酸产业发展的多主体共同参与模式。产业创新联盟是生物医药领域多主体共同参与链式发展模式的主要形式。结论多主体共同参与的链式发展模式是国内小核酸产业发展较优的选择。
Objective To study the development mode suitable for the domestic small nucleic acid pharmaceutical industry. Methods By analyzing the status of small nucleic acid industry, domestic and foreign small nucleic acid development model and the characteristics of patent technology to determine the development model for domestic industries. Results Based on the evaluation of the current situation, the mode of common participation of multiple subjects suitable for the development of domestic small nucleic acid industry was determined. Industry Innovation Alliance is the main form of multi-agent participation in chain medicine development mode in biomedicine field. Conclusion The multi-agent participation chain development mode is the preferred choice for the development of domestic small nucleic acid industry.